cancer care

Dr Christian Ntizimira, MD, MMsGHE, Founder and Executive Director of the African Center for Research on End-of-Life Care (ACREOL), and author of “The Safari Concept: An African Framework on End-of-Life Care,” speaks about dignity, suffering, and reimagining care at the…

The conversation starts with a small detail that quickly becomes memorable. There is no coffee. On a podcast built around conversations over coffee, Professor Ricky Dylan Frazer, Consultant Medical Oncologist at Velindre Cancer Centre, Deputy CEO of the Immuno-Oncology Clinical…

If you try to list everything Charles Balch has done, you quickly realize the list does not help you understand the man. He has led some of the most important institutions in oncology. He has built systems that are now…

In oncology, progress is measured in survival rates, response curves, and treatment gains. But those numbers rest on a quieter assumption: that health systems can deliver what science makes possible. When they cannot, progress becomes uneven—not in discovery, but in…

From genetics to palliative care, clinician-scientist Rita Canário reflects on building a career in Oncology  that bridges research, patient care, and the human side of medicine and why this integration is essential for the future of oncology. “I was never…

Global health has become very good at diagnosing problems but far less effective at implementing solutions. That gap is where Isabel Mestres has built her career. As CEO of City Cancer Challenge, she is known not as a theorist or…

Too Much Hope is a False Hope K. still remembers the moment she heard the diagnosis. The room felt suddenly smaller, the air heavier, and time strangely suspended. “You wake up in a void, alone and scared,” she says. “But…

A Global Summit, a Personal Reckoning At the European Society for Medical Oncology (ESMO) Leadership Summit in Singapore, discussions moved rapidly from antibody–drug conjugates to next-generation sequencing and the expanding role of immunotherapy. Clinical trial curves filled large screens, and…

“I’m a scientist first and foremost. I don’t remember a time not thinking about being a scientist.” What Karen Knudsen, the CEO of Parker Institute for Cancer Immunotherapy, remembers clearly is the pull not toward prestige or power, but toward…

Scientific discovery drives oncology forward, but progress only truly begins when knowledge is turned into action. Every issue of CancerWorld explores the people, ideas, and systems shaping the future of oncology. Scientific breakthroughs remain essential, but their true value emerges…